Healthcare Happenings

Written by The Rounds

healthcare happenings

As healthcare professionals, we know how difficult it is for you to keep current on all news in technology and treatments – that’s why we are here to help you. So, keep reading for the rundown on all things medicine during the week of November 7th.

1. Using Anti-Viral Drugs in the Treatment of COVID-19

Anti-viral drug in the treatment of covid-19

Pfizer, one of the leading COVID-19 vaccine manufacturers recently announced that its experimental anti-viral medication used to treat early Coronavirus infections looks promising enough to stop clinical trials and apply for US FDA approval.
For more on this article click here 🔗

2. Post-Operative Prostate Bed Radiotherapy for Prostate Cancer Patients

A study presented at the Plenary Session of the American Society for Radiation Oncology’s Annual Meeting found that Hypofractionated post-operative prostate bed radiotherapy did not increase overall genitourinary or gastrointestinal toxicity in prostate cancer patients.
Read about the study here 🔗

3. Tofacitinib in Juvenile Idiopathic Arthritis

A double-blind, placebo-controlled, withdrawal phase 3 randomized trial focused on tofacitinib in juvenile idiopathic arthritis was recently published in The Lancet. This trial worked to assess the efficacy and safety of tofacitinib in comparison to placebo in patients with polyarticular course juvenile idiopathic arthritis (JIA).
Read more about the trial here 🔗

4. Keeping Patients Interested in Virtual Care

Keeping patients interested in virtual care

The COVID-19 pandemic forced virtual patient care to rise to the challenge. Healthcare professionals and patients themselves adapted to the new normal of a patient visit — but will they want to continue this way?
Click here for advice on keeping patients engaged in virtual care post-pandemic 🔗

5. HPV Vaccination Correlated to Cervical Cancer Reduction in Young Women

Newly published in The Lancet, researchers found that the HPV vaccination greatly reduced the chance of young women in England being diagnosed with cervical cancer. Through assessment of the HPV bivalent vaccine on clinical outcomes of young women who received the dose in September 2008 researchers calculated the rate among 3 cohorts of women, both vaccinated and not.
Learn more about their findings here 🔗

Visit The Rounds on Twitter and Instagram for more industry news and updates. 💻

Connect with your medical peers and discuss these topics in a secure space in The Rounds network!